Revealing hidden genetic diagnoses in the ocular anterior segment disorders.


Journal

Genetics in medicine : official journal of the American College of Medical Genetics
ISSN: 1530-0366
Titre abrégé: Genet Med
Pays: United States
ID NLM: 9815831

Informations de publication

Date de publication:
10 2020
Historique:
received: 30 01 2020
accepted: 20 05 2020
revised: 19 05 2020
pubmed: 6 6 2020
medline: 28 4 2021
entrez: 6 6 2020
Statut: ppublish

Résumé

Ocular anterior segment disorders (ASDs) are clinically and genetically heterogeneous, and genetic diagnosis often remains elusive. In this study, we demonstrate the value of a combined analysis protocol using phenotypic, genomic, and pedigree structure data to achieve a genetic conclusion. We utilized a combination of chromosome microarray, exome sequencing, and genome sequencing with structural variant and trio analysis to investigate a cohort of 41 predominantly sporadic cases. We identified likely causative variants in 54% (22/41) of cases, including 51% (19/37) of sporadic cases and 75% (3/4) of cases initially referred as familial ASD. Two-thirds of sporadic cases were found to have heterozygous variants, which in most cases were de novo. Approximately one-third (7/22) of genetic diagnoses were found in rarely reported or recently identified ASD genes including PXDN, GJA8, COL4A1, ITPR1, CPAMD8, as well as the new phenotypic association of Axenfeld-Rieger anomaly with a homozygous ADAMTS17 variant. The remainder of the variants were in key ASD genes including FOXC1, PITX2, CYP1B1, FOXE3, and PAX6. We demonstrate the benefit of detailed phenotypic, genomic, variant, and segregation analysis to uncover some of the previously "hidden" heritable answers in several rarely reported and newly identified ocular ASD-related disease genes.

Identifiants

pubmed: 32499604
doi: 10.1038/s41436-020-0854-x
pii: S1098-3600(21)00746-2
pmc: PMC7521990
doi:

Substances chimiques

FOXE3 protein, human 0
Forkhead Transcription Factors 0
Cytochrome P-450 CYP1B1 EC 1.14.14.1
ADAMTS Proteins EC 3.4.24.-
ADAMTS17 protein, human EC 3.4.24.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1623-1632

Références

Reis LM, Semina EV. Genetics of anterior segment dysgenesis disorders. Curr Opin Ophthalmol. 2011;22:314–324.
doi: 10.1097/ICU.0b013e328349412b
Reis LM, Tyler RC, Volkmann Kloss BA, et al. PITX2 and FOXC1 spectrum of mutations in ocular syndromes. Eur J Hum Genet. 2012;20:1224–1233.
doi: 10.1038/ejhg.2012.80
Weh E, Reis LM, Happ HC, et al. Whole exome sequence analysis of Peters anomaly. Hum Genet. 2014;133:1497–1511.
doi: 10.1007/s00439-014-1481-x
Ma AS, Grigg JR, Prokudin I, Flaherty M, Bennetts B, Jamieson RV. New mutations in GJA8 expand the phenotype to include total sclerocornea. Clin Genet. 2018;93:155–159.
doi: 10.1111/cge.13045
Ma AS, Grigg JR, Ho G, et al. Sporadic and familial congenital cataracts: mutational spectrum and new diagnoses using next-generation sequencing. Hum Mutat. 2016;37:371–384.
doi: 10.1002/humu.22948
Ma AS, Grigg JR, Jamieson RV. Phenotype-genotype correlations and emerging pathways in ocular anterior segment dysgenesis. Hum Genet. 2018;138:899–915.
doi: 10.1007/s00439-018-1935-7
Nash BM, Symes R, Goel H, et al. NMNAT1 variants cause cone and cone-rod dystrophy. Eur J Hum Genet. 2018;26:428–433.
doi: 10.1038/s41431-017-0029-7
Prokudin I, Simons C, Grigg JR, et al. Exome sequencing in developmental eye disease leads to identification of causal variants in GJA8, CRYGC, PAX6 and CYP1B1. Eur J Hum Genet. 2014;22:907–915.
doi: 10.1038/ejhg.2013.268
Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–424.
doi: 10.1038/gim.2015.30
Matias-Perez D, Garcia-Montano LA, Cruz-Aguilar M, et al. Identification of novel pathogenic variants and novel gene-phenotype correlations in Mexican subjects with microphthalmia and/or anophthalmia by next-generation sequencing. J Hum Genet. 2018;63:1169–1180.
doi: 10.1038/s10038-018-0504-1
Meuwissen ME, Halley DJ, Smit LS, et al. The expanding phenotype of COL4A1 and COL4A2 mutations: clinical data on 13 newly identified families and a review of the literature. Genet Med. 2015;17:843–853.
doi: 10.1038/gim.2014.210
Patel N, Khan AO, Alsahli S, et al. Genetic investigation of 93 families with microphthalmia or posterior microphthalmos. Clin Genet. 2018;93:1210–1222.
doi: 10.1111/cge.13239
Zazo-Seco C, Plaisancie J, Bitoun P, et al. Novel PXDN biallelic variants in patients with microphthalmia and anterior segment dysgenesis. J Hum Genet. 2020;65:487–491.
doi: 10.1038/s10038-020-0726-x
Morales J, Al-Sharif L, Khalil DS, et al. Homozygous mutations in ADAMTS10 and ADAMTS17 cause lenticular myopia, ectopia lentis, glaucoma, spherophakia, and short stature. Am J Hum Genet. 2009;85:558–568.
doi: 10.1016/j.ajhg.2009.09.011
Vincent A, Billingsley G, Priston M, et al. Phenotypic heterogeneity of CYP1B1: mutations in a patient with Peters’ anomaly. J Med Genet. 2001;38:324–326.
doi: 10.1136/jmg.38.5.324
Teixeira LB, Zhao Y, Dubielzig RR, Sorenson CM, Sheibani N. Ultrastructural abnormalities of the trabecular meshwork extracellular matrix in Cyp1b1-deficient mice. Vet Pathol. 2015;52:397–403.
doi: 10.1177/0300985814535613
Cheong SS, Hentschel L, Davidson AE, et al. Mutations in CPAMD8 cause a unique form of autosomal-recessive anterior segment dysgenesis. Am J Hum Genet. 2016;99:1338–1352.
doi: 10.1016/j.ajhg.2016.09.022
Ng WY, Pasutto F, Bardakjian TM, et al. A puzzle over several decades: eye anomalies with FRAS1 and STRA6 mutations in the same family. Clin Genet. 2013;83:162–168.
doi: 10.1111/j.1399-0004.2012.01851.x
McEntagart M, Williamson KA, Rainger JK, et al. A restricted repertoire of de novo mutations in ITPR1 cause Gillespie syndrome with evidence for dominant-negative effect. Am J Hum Genet. 2016;98:981–992.
doi: 10.1016/j.ajhg.2016.03.018
Jackson BC, Carpenter C, Nebert DW, Vasiliou V. Update of human and mouse forkhead box (FOX) gene families. Hum Genomics. 2010;4:345–352.
doi: 10.1186/1479-7364-4-5-345
Gripp KW, Hopkins E, Jenny K, Thacker D, Salvin J. Cardiac anomalies in Axenfeld–Rieger syndrome due to a novel FOXC1 mutation. Am J Med Genet A. 2013;161A:114–119.
doi: 10.1002/ajmg.a.35697
Murphy TC, Saleem RA, Footz T, Ritch R, McGillivray B, Walter MA. The wing 2 region of the FOXC1 forkhead domain is necessary for normal DNA-binding and transactivation functions. Invest Ophthalmol Vis Sci. 2004;45:2531–2538.
doi: 10.1167/iovs.04-0167
Clark KL, Halay ED, Lai E, Burley SK. Co-crystal structure of the HNF-3/fork head DNA-recognition motif resembles histone H5. Nature. 1993;364:412–420.
doi: 10.1038/364412a0
Aldinger KA, Lehmann OJ, Hudgins L, et al. FOXC1 is required for normal cerebellar development and is a major contributor to chromosome 6p25.3 Dandy-Walker malformation. Nat Genet. 2009;41:1037–1042.
doi: 10.1038/ng.422
D’Haene B, Meire F, Claerhout I, et al. Expanding the spectrum of FOXC1 and PITX2 mutations and copy number changes in patients with anterior segment malformations. Invest Ophthalmol Vis Sci. 2011;52:324–333.
doi: 10.1167/iovs.10-5309
Xia K, Wu L, Liu X, et al. Mutation in PITX2 is associated with ring dermoid of the cornea. J Med Genet. 2004;41:e129.
doi: 10.1136/jmg.2004.022434
Bobilev AM, McDougal ME, Taylor WL, Geisert EE, Netland PA, Lauderdale JD. Assessment of PAX6 alleles in 66 families with aniridia. Clin Genet. 2016;89:669–677.
doi: 10.1111/cge.12708
Tzoulaki I, White IM, Hanson IM. PAX6 mutations: genotype–phenotype correlations. BMC Genet. 2005;6:27.
doi: 10.1186/1471-2156-6-27
Alsaif HS, Khan AO, Patel N, et al. Congenital glaucoma and CYP1B1: an old story revisited. Hum Genet. 2018;138:1043–1049.
doi: 10.1007/s00439-018-1878-z
Safari I, Suri F, Haji-Seyed-Javadi R, Yazdani S, Elahi E. The p.Gly61Glu mutation in CYP1B1 affects the extracellular matrix in glaucoma patients. Ophthalmic Res. 2016;56:98–103.
doi: 10.1159/000443508
Kwan KM. Coming into focus: the role of extracellular matrix in vertebrate optic cup morphogenesis. Dev Dyn. 2014;243:1242–1248.
doi: 10.1002/dvdy.24162
Bryan CD, Casey MA, Pfeiffer RL, Jones BW, Kwan KM. Optic cup morphogenesis requires neural crest-mediated basement membrane assembly. Development. 2020;147:dev181420.
doi: 10.1242/dev.181420
Zagaglia S, Selch C, Nisevic JR, et al. Neurologic phenotypes associated with COL4A1/2 mutations: expanding the spectrum of disease. Neurology. 2018;91:e2078–e2088.
doi: 10.1212/WNL.0000000000006567
Mao M, Kiss M, Ou Y, Gould DB. Genetic dissection of anterior segment dysgenesis caused by a Col4a1 mutation in mouse. Dis Model Mech. 2017;10:475–485.
doi: 10.1242/dmm.027888
Sirokmany G, Kovacs HA, Lazar E, et al. Peroxidasin-mediated crosslinking of collagen IV is independent of NADPH oxidases. Redox Biol. 2018;16:314–321.
doi: 10.1016/j.redox.2018.03.009
Yan X, Sabrautzki S, Horsch M, et al. Peroxidasin is essential for eye development in the mouse. Hum Mol Genet. 2014;23:5597–5614.
doi: 10.1093/hmg/ddu274
Choi A, Lao R, Ling-Fung Tang P, et al. Novel mutations in PXDN cause microphthalmia and anterior segment dysgenesis. Eur J Hum Genet. 2015;23:337–341.
doi: 10.1038/ejhg.2014.119
Hubmacher D, Schneider M, Berardinelli SJ, et al. Unusual life cycle and impact on microfibril assembly of ADAMTS17, a secreted metalloprotease mutated in genetic eye disease. Sci Rep. 2017;7:41871.
doi: 10.1038/srep41871
Clark MM, Stark Z, Farnaes L, et al. Meta-analysis of the diagnostic and clinical utility of genome and exome sequencing and chromosomal microarray in children with suspected genetic diseases. NPJ Genom Med. 2018;3:16.
doi: 10.1038/s41525-018-0053-8
Schwarze K, Buchanan J, Taylor JC, Wordsworth S. Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literature. Genet Med. 2018;20:1122–1130.
doi: 10.1038/gim.2017.247

Auteurs

Alan Ma (A)

Eye Genetics Research Unit, The Children's Hospital at Westmead, Save Sight Institute, Children's Medical Research Institute, University of Sydney, Sydney, NSW, Australia.
Department of Clinical Genetics, Western Sydney Genetics Program, The Children's Hospital at Westmead, Sydney, NSW, Australia.
Disciplines of Genomic Medicine & Child and Adolescent Health, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.

Saira Yousoof (S)

Eye Genetics Research Unit, The Children's Hospital at Westmead, Save Sight Institute, Children's Medical Research Institute, University of Sydney, Sydney, NSW, Australia.
Subang Jaya Medical Centre, Ramsay Sime Darby Healthcare, Selangor, Malaysia.

John R Grigg (JR)

Eye Genetics Research Unit, The Children's Hospital at Westmead, Save Sight Institute, Children's Medical Research Institute, University of Sydney, Sydney, NSW, Australia.
Department of Ophthalmology, The Children's Hospital at Westmead, Sydney, NSW, Australia.
Discipline of Ophthalmology, University of Sydney, Sydney, NSW, Australia.

Maree Flaherty (M)

Department of Ophthalmology, The Children's Hospital at Westmead, Sydney, NSW, Australia.
Discipline of Ophthalmology, University of Sydney, Sydney, NSW, Australia.

Andre E Minoche (AE)

Kinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.

Mark J Cowley (MJ)

Kinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.
Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Randwick, New South Wales, Australia.
St Vincent's Clinical School, Faculty of Medicine, UNSW Australia, Sydney, NSW, Australia.

Benjamin M Nash (BM)

Eye Genetics Research Unit, The Children's Hospital at Westmead, Save Sight Institute, Children's Medical Research Institute, University of Sydney, Sydney, NSW, Australia.
Disciplines of Genomic Medicine & Child and Adolescent Health, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
Sydney Genome Diagnostics, Western Sydney Genetics Program, The Children's Hospital at Westmead, Sydney, NSW, Australia.

Gladys Ho (G)

Disciplines of Genomic Medicine & Child and Adolescent Health, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
Sydney Genome Diagnostics, Western Sydney Genetics Program, The Children's Hospital at Westmead, Sydney, NSW, Australia.

Thet Gayagay (T)

Sydney Genome Diagnostics, Western Sydney Genetics Program, The Children's Hospital at Westmead, Sydney, NSW, Australia.

Tiffany Lai (T)

Sydney Genome Diagnostics, Western Sydney Genetics Program, The Children's Hospital at Westmead, Sydney, NSW, Australia.

Elizabeth Farnsworth (E)

Sydney Genome Diagnostics, Western Sydney Genetics Program, The Children's Hospital at Westmead, Sydney, NSW, Australia.

Emma L Hackett (EL)

Sydney Genome Diagnostics, Western Sydney Genetics Program, The Children's Hospital at Westmead, Sydney, NSW, Australia.

Katrina Fisk (K)

Sydney Genome Diagnostics, Western Sydney Genetics Program, The Children's Hospital at Westmead, Sydney, NSW, Australia.

Karen Wong (K)

Sydney Genome Diagnostics, Western Sydney Genetics Program, The Children's Hospital at Westmead, Sydney, NSW, Australia.

Katherine J Holman (KJ)

Sydney Genome Diagnostics, Western Sydney Genetics Program, The Children's Hospital at Westmead, Sydney, NSW, Australia.

Gemma Jenkins (G)

Sydney Genome Diagnostics, Western Sydney Genetics Program, The Children's Hospital at Westmead, Sydney, NSW, Australia.

Anson Cheng (A)

Eye Genetics Research Unit, The Children's Hospital at Westmead, Save Sight Institute, Children's Medical Research Institute, University of Sydney, Sydney, NSW, Australia.

Frank Martin (F)

Department of Ophthalmology, The Children's Hospital at Westmead, Sydney, NSW, Australia.
Discipline of Ophthalmology, University of Sydney, Sydney, NSW, Australia.

Tanya Karaconji (T)

Department of Ophthalmology, The Children's Hospital at Westmead, Sydney, NSW, Australia.
Discipline of Ophthalmology, University of Sydney, Sydney, NSW, Australia.
Save Sight Institute, Sydney Eye Hospital, Sydney, NSW, Australia.

James E Elder (JE)

Department of Ophthalmology, Royal Children's Hospital, Parkville, VIC, Australia.
Department of Paediatrics, University of Melbourne, Parkville, VIC, Australia.

Annabelle Enriquez (A)

Department of Clinical Genetics, Western Sydney Genetics Program, The Children's Hospital at Westmead, Sydney, NSW, Australia.
Disciplines of Genomic Medicine & Child and Adolescent Health, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.

Meredith Wilson (M)

Department of Clinical Genetics, Western Sydney Genetics Program, The Children's Hospital at Westmead, Sydney, NSW, Australia.
Disciplines of Genomic Medicine & Child and Adolescent Health, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.

David J Amor (DJ)

Murdoch Children's Research Institute and University of Melbourne, Melbourne, VIC, Australia.
Department of Paediatrics, Royal Children's Hospital, Melbourne, VIC, Australia.

Chloe A Stutterd (CA)

Murdoch Children's Research Institute and University of Melbourne, Melbourne, VIC, Australia.
Department of Paediatrics, Royal Children's Hospital, Melbourne, VIC, Australia.

Benjamin Kamien (B)

Hunter Genetics, Newcastle, NSW, Australia.

John Nelson (J)

Genetic Services of Western Australia, King Edward Memorial Hospital, Perth, WA, Australia.

Marcel E Dinger (ME)

Kinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.
School of Biotechnology and Biomolecular Sciences, Faculty of Science, UNSW Sydney, Sydney, NSW, Australia.

Bruce Bennetts (B)

Disciplines of Genomic Medicine & Child and Adolescent Health, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
Sydney Genome Diagnostics, Western Sydney Genetics Program, The Children's Hospital at Westmead, Sydney, NSW, Australia.

Robyn V Jamieson (RV)

Eye Genetics Research Unit, The Children's Hospital at Westmead, Save Sight Institute, Children's Medical Research Institute, University of Sydney, Sydney, NSW, Australia. rjamieson@cmri.org.au.
Department of Clinical Genetics, Western Sydney Genetics Program, The Children's Hospital at Westmead, Sydney, NSW, Australia. rjamieson@cmri.org.au.
Disciplines of Genomic Medicine & Child and Adolescent Health, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia. rjamieson@cmri.org.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH